+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-lived inhibition of anodal current-induced vasodilation by oral single high dose aspirin

Long-lived inhibition of anodal current-induced vasodilation by oral single high dose aspirin

FASEB Journal 17(4-5): Abstract No 77 8

Previously we reported that acetyl salicyclic acid (aspirin) inhibits anodal current-induced cutaneous vasodilation (AnVAS). Aspirin irreversibly blocks cyclooxygenase (COX), which is necessary for prostaglandin (PG) synthesis. Recovery of COX is faster in endothelial or smooth muscle cells (3 to 36 hours) than in platelets (up to 10 days). By assessing the time course of aspirin inhibition of AnVAS, the origin of PG involved in this response may be identified. Forearm AnVAS was recorded following 20 minutes of 5 min, 0.10mA transcutaneous anodal current application, using deionised water as a vehicle. Peak AnVAS was normalised relative to maximal cutaneous vasodilation (44(C local heating). Experiments were performed before and 2 hours, 10 hours, 3 days, 7 days, 10 days, and 14 days after blinded administration of 1-g aspirin or placebo.Peak AnVAS (mean(SD; aspirin vs placebo) was 13.6(14.5 vs. 65.0(32.1 (2 hours; p< 0.05), 14.7(4.2 vs. 87.5(31.9 (10 hours; p< 0.05), 18.1(10.2 vs. 71.6(26.8 (3 days; p< 0.05), 42.5(23.4 vs. 73.3(26.8 (7 days; non significant, NS), 60.2(24.3 vs. 75.2(26.9 (10 days; NS), 52.1(18.5 vs. 67.9(32.1 (14 days; NS). Inhibition of AnVAS persisted long after endothelial and smooth muscle COX are restored. Thus, PG involved in AnVAS are not endothelial-or smooth muscle-derived. The mechanism of prolonged inhibition of AnVAS by aspirin remains to be identified.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 035234955

Download citation: RISBibTeXText

Related references

Oral single high-dose aspirin results in a long-lived inhibition of anodal current-induced vasodilatation. British Journal of Pharmacology 137(3): 384-390, 2002

Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294(5): R1420-6, 2008

Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 285(1): R155-R161, 2003

Inhibition of arachidonate-induced human platelet aggregation by a single low oral dose of aspirin in combination with a thromboxane synthase inhibitor. Thrombosis and Haemostasis 52(2): 215, 1984

Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Thrombosis and Haemostasis 95(6): 1042-1043, 2006

Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms. Journal of Applied Physiology 99(4): 1538-1544, 2005

Should high dose intravenous aspirin replace low dose oral aspirin in acute coronary vascular injury. Clinical Research 38(4): 964A, 1990

Current-induced vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current onset and involves aspirin sensitive mechanisms. Journal of Vascular Research 39(1): 59-71, 2002

Current-Induced Vasodilation during Water Iontophoresis (5 min, 0.10 mA) Is Delayed from Current Onset and Involves Aspirin Sensitive Mechanisms. Journal of Vascular Research 39(1): 59-71, 2002

Aspirin resistance among long-term aspirin users after carotid endarterectomy and controls: flow cytometric measurement of aspirin-induced platelet inhibition. Journal of Vascular Surgery 45(6): 1142-7; Discussion 1147, 2007

High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury. Journal Of The American College Of Cardiology. 21(2): 502-510, 1993

In vivo blockade of V1 receptors in humans by conivaptan Dose-dependent inhibition of vasopressin-induced platelet aggregation after single oral dose. European Heart Journal 21(Abstract Suppl.): 594, August-September, 2000

Even low-dose aspirin inhibits arachidonic acid-induced vasodilation in heart failure. Clinical Pharmacology and Therapeutics 67(5): 530-537, 2000

COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood. Open Cardiovascular Medicine Journal 4: 198-205, 2011

High dose intravenous aspirin vs low dose intravenous or oral aspirin in experimental coronary vascular injury. Journal of the American College of Cardiology 17(2 SUPPL A): 144A, 1991